Related Experiment Video
Updated: Jan 20, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Clinical Decision Support to Reduce Contrast-Induced Kidney Injury During Cardiac Catheterization: Design of a
Matthew T James1, Bryan J Har2, Ben D Tyrrell3
1Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute of Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
This study introduces a multifaceted intervention to reduce contrast-induced acute kidney injury (CI-AKI) in cardiac catheterization patients. The goal is to improve patient safety through advanced risk identification and evidence-based protocols.
Area of Science:
- Cardiology
- Nephrology
- Health Services Research
Background:
- Contrast-induced acute kidney injury (CI-AKI) is a significant complication following invasive cardiac procedures.
- While quality improvement programs show promise, high-quality evidence on clinical decision support for CI-AKI prevention is lacking.
Purpose of the Study:
- To implement and evaluate an evidence-based, multifaceted intervention to reduce CI-AKI incidence.
- To assess the impact of clinical decision support on CI-AKI prevention strategies and patient outcomes.
Main Methods:
- The Contrast-Reducing Injury Sustained by Kidneys (Contrast RISK) study employs a cluster-randomized stepped-wedge design across Alberta's cardiac catheterization labs.
- The intervention includes automated risk identification, point-of-care guidance, personalized fluid optimization recommendations, and follow-up.
- Implementation utilizes cardiologist academic detailing, computerized decision support, and audit/feedback mechanisms.
Main Results:
- Primary outcome: CI-AKI incidence.
- Secondary outcomes: CI-AKI avoidance strategies, major adverse kidney and cardiovascular events.
- Economic evaluation will be conducted alongside the trial.
Conclusions:
- The Contrast RISK study utilizes health IT, evidence-based protocols, and feedback to mitigate CI-AKI in cardiac catheterization.
- Successful implementation could lead to broad scalability and improved cardiac catheterization safety.
Related Concept Videos
15:45Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
09:09In Silico Clinical Trials for Cardiovascular Disease
06:25Kidney Regeneration in Adult Zebrafish by Gentamicin Induced Injury
13:25Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Cardiac Catheterization II: Right Heart Catheterization
09:02A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

